Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,137,377
+$79,475 QoQ
Shares Held
20,019
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#342
of 1,603 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARIETTA INVESTMENT PARTNERS LLC holds $16,315,000 across 5 Drug Manufacturers - General names. NVS ranks #3 (19.2% of the industry book) .
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,137,377 | 20,019 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,057,902 | 20,019 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,514,335 | 18,237 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,276,131 | 17,749 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,069,755 | 17,104 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,973,641 | 17,704 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,733,480 | 17,814 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,433,133 | 21,154 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,278,669 | 21,404 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,083,951 | 21,544 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,135,717 | 21,152 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,372,257 | 13,472 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,350,377 | 13,382 | Shares | Sole | 2023-08-14 | |
| 2021-06-30 | $215,508 | 2,362 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $200,947 | 2,128 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||